ToxSci Advance Access originally published online on March 31, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Toxicological Sciences 79, 233-241 (2004)
Toxicological Sciences vol. 79 no. 2 © Society of Toxicology; all rights reserved.
Regulation of CYP2E1 by Ethanol and Palmitic Acid and CYP4A11 by Clofibrate in Primary Cultures of Human Hepatocytes
* California Toxicology Research Institute, 1989 Palomar Oaks Way, Suite B, Carlsbad, California 92009, and Institute for Biomedical Research, Hackensack University Medical Center, Hackensack, New Jersey 07601
Received January 12, 2004; accepted March 1, 2004
CYP2E1 and CYP4A11 are cytochrome P450 enzymes that are regulated by physiological conditions including diabetes and fasting. In addition, the xenochemical clofibrate has been reported to induce both rodent CYP2E1 and CYP4A. These findings suggest similar modes of regulation. Also in common to both enzymes is the ability to metabolize fatty acids such as laurate and arachidonic acid. Here, we used primary cultures of human hepatocytes to determine if certain xenochemicals could regulate CYP2E1 and CYP4A11. Ethanol significantly (p < 0.05) increased expression of CYP2E1 mRNA by 216 ± 32% of control, but did not alter CYP4A11 mRNA accumulation (145 ± 22% of control). In contrast, hepatocytes exposed to ethanol exhibited only a slight elevation in CYP2E1 protein (122 ± 13% of control) and a negligible effect on CYP4A11 protein. Clofibrate significantly (p < 0.05) enhanced both CYP4A11 mRNA and protein by 239 ± 30% and 154 ± 10% of control, respectively, but did not increase CYP2E1. Because rodent CYP4A is reportedly regulated by fatty acids through peroxisome proliferator activated receptor 
(PPAR) and CYP2E1 is induced by high fat diets, we examined the effects of a medium chain fatty acid, palmitate on CYP2E1 mRNA content. Palmitic acid significantly (p < 0.05) increased CYP2E1 mRNA to 326 ± 57% of control. Collectively, results presented here identify agents that enhance CYP2E1 and CYP4A11 at the transcription level and suggest that fatty acids may represent a similar mode of regulation for these P450 enzymes. The lack of induction of CYP2E1 protein by ethanol in human hepatocytes indicates that for certain P450 enzymes, isolated hepatocytes may not be an adequate tool for predicting in vivo responses.
Key Words: human hepatocytes; CYP4A11; CYP2E1; ethanol; palmitate; clofibrate.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Richert, G. Tuschl, C. Viollon-Abadie, N. Blanchard, A. Bonet, B. Heyd, N. Halkic, E. Wimmer, H. Dolgos, and S. O. Mueller Species Differences in the Response of Liver Drug-Metabolizing Enzymes to (S)-4-O-Tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric Acid (EMD 392949) in Vivo and in Vitro Drug Metab. Dispos., April 1, 2008; 36(4): 702 - 714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Xu, V. Y. Ng, D. L. Kroetz, and P. R. O. de Montellano CYP4 Isoform Specificity in the {omega}-Hydroxylation of Phytanic Acid, a Potential Route to Elimination of the Causative Agent of Refsum's Disease J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 835 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Graham, B. Goodwin, R. V. Merrihew, W. L. Krol, and E. L. LeCluyse Cloning, Tissue Expression, and Regulation of Beagle Dog CYP4A Genes Toxicol. Sci., August 1, 2006; 92(2): 356 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-F. Yueh, M. Kawahara, and J. Raucy HIGH VOLUME BIOASSAYS TO ASSESS CYP3A4-MEDIATED DRUG INTERACTIONS: INDUCTION AND INHIBITION IN A SINGLE CELL LINE Drug Metab. Dispos., January 1, 2005; 33(1): 38 - 48. [Abstract] [Full Text] [PDF]
|
|